NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 09/18/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization7,722.14 mln
Float121 mln
Earnings Date10/28/2026
EPS
0.38
Overpriced
P / E
114
Highly speculative
Piotroski F-Score
4
/ 9
Borderline
Beneish M-Score
-1.43
Manipulation likely
1-Year Forecast
56.00
Strong upside
Relative Strength
18
/ 100
Significantly lagging
Business Description
Alkermes is an Irish biopharmaceutical company founded in 1987 that develops and sells medicines for serious mental health and neurological conditions, including schizophrenia, bipolar disorder, and opioid and alcohol dependence. Its approved treatments are sold primarily in the United States, with additional operations in Ireland and other markets. The company also licenses its drug delivery technology to other pharmaceutical firms, supporting their efforts to develop and manufacture their own products.
